Vascular growth factors in cerebral ischemia

被引:70
作者
Croll, SD [1 ]
Wiegand, SJ [1 ]
机构
[1] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA
关键词
vascular endothelial growth factor (VEGF); angiopoietin; Tie receptors; Flt; Flk; VEGFR1; VEGFR2; stroke;
D O I
10.1385/MN:23:2-3:121
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
During the past decade, there has been a surge of interest in growth factors (GFs) that act selectively on vascular endothelium and perivascular cells. Studies employing mutant mice or the administration of recombinant proteins have suggested that these factors not only mediate the proliferation of endothelial cells, but also regulate vascular differentiation, regression, and permeability. During and after cerebral ischemia, brain vasculature becomes leaky and unstable, and the normally impermeable blood-brain barrier breaks down. Several days after the ischemic insult, endothelial cells begin to proliferate, and angiogenesis occurs. Expression studies have shown that key vascular GFs are regulated, during these processes, in a complex and coordinated manner. The distinct pattern of regulation exhibited by each vascular GF suggests a unique role for each factor during the initial vascular destabilization and subsequent angiogenesis that occurs after cerebral ischemia. Data from studies in other biological systems support these suggested roles. Thus, manipulation of vascular GFs may prove to be an effective means of stabilizing or enriching brain vasculature after ischemia, and ameliorating the detrimental effects of blood-brain barrier breakdown and vessel regression after stroke.
引用
收藏
页码:121 / 135
页数:15
相关论文
共 119 条
[11]   VEGF gene therapy: stimulating angiogenesis or angioma-genesis? [J].
Carmeliet, P .
NATURE MEDICINE, 2000, 6 (10) :1102-1103
[12]  
Carmeliet P, 2000, ANN NY ACAD SCI, V902, P249
[13]   Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele [J].
Carmeliet, P ;
Ferreira, V ;
Breier, G ;
Pollefeyt, S ;
Kieckens, L ;
Gertsenstein, M ;
Fahrig, M ;
Vandenhoeck, A ;
Harpal, K ;
Eberhardt, C ;
Declercq, C ;
Pawling, J ;
Moons, L ;
Collen, D ;
Risau, W ;
Nagy, A .
NATURE, 1996, 380 (6573) :435-439
[14]  
Chédotal A, 1998, DEVELOPMENT, V125, P4313
[15]   Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkB-dependent inducible nitric oxide synthase and cyclooxygenase-2 [J].
Chiarugi, V ;
Magnelli, L ;
Chiarugi, A ;
Gallo, O .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1999, 125 (8-9) :525-528
[16]   Anti-adhesion molecule and nitric oxide protection strategies in ischemic stroke [J].
Chopp, M ;
Zhang, ZG .
CURRENT OPINION IN NEUROLOGY, 1996, 9 (01) :68-72
[17]   Antibodies against adhesion molecules reduce apoptosis after transient middle cerebral artery occlusion in rat brain [J].
Chopp, M ;
Li, Y ;
Jiang, N ;
Zhang, RL ;
Prostak, J .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (04) :578-584
[18]   Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat [J].
Cobbs, CS ;
Chen, J ;
Greenberg, DA ;
Graham, SH .
NEUROSCIENCE LETTERS, 1998, 249 (2-3) :79-82
[19]  
CROLL SD, 2000, SOC NEUR ABSTR, V26, P1811
[20]   Isolation of Angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning [J].
Davis, S ;
Aldrich, TH ;
Jones, PF ;
Acheson, A ;
Compton, DL ;
Jain, V ;
Ryan, TE ;
Bruno, J ;
Radziejewski, C ;
Maisonpierre, PC ;
Yancopoulos, GD .
CELL, 1996, 87 (07) :1161-1169